Published in J Neurol Neurosurg Psychiatry on March 01, 2006
Smoking duration, intensity, and risk of Parkinson disease. Neurology (2010) 3.19
Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee. PLoS Genet (2011) 2.28
Dietary and lifestyle variables in relation to incidence of Parkinson's disease in Greece. Eur J Epidemiol (2013) 1.72
Temporal relationship between cigarette smoking and risk of Parkinson disease. Neurology (2007) 1.59
Caffeine intake, smoking, and risk of Parkinson disease in men and women. Am J Epidemiol (2012) 1.28
Alcohol-impaired driving behavior and sensation-seeking disposition in a college population receiving routine care at campus health services centers. Accid Anal Prev (2009) 1.14
Differential effects of dopaminergic therapies on dorsal and ventral striatum in Parkinson's disease: implications for cognitive function. Parkinsons Dis (2011) 1.13
Depression and suicide ideation among students accessing campus health care. Am J Orthopsychiatry (2011) 1.11
Caffeine and progression of Parkinson disease. Clin Neuropharmacol (2008) 0.98
Personality traits in patients with Parkinson's disease: assessment and clinical implications. J Neurol (2011) 0.96
A genetic basis for the variable effect of smoking/nicotine on Parkinson's disease. Pharmacogenomics J (2012) 0.91
Alpha-synuclein, alcohol use disorders, and Parkinson disease: a case-control study. Parkinsonism Relat Disord (2009) 0.90
Psychosocial risk factors, pre-motor symptoms and first-time hospitalization with Parkinson's disease: a prospective cohort study. Eur J Neurol (2013) 0.89
Prospective cohort study of impulse control disorders in Parkinson's disease. Mov Disord (2013) 0.88
Premotor biomarkers for Parkinson's disease - a promising direction of research. Transl Neurodegener (2012) 0.86
Association between Parkinson's Disease and Cigarette Smoking, Rural Living, Well-Water Consumption, Farming and Pesticide Use: Systematic Review and Meta-Analysis. PLoS One (2016) 0.85
Impulse control disorders in Parkinson's disease: the role of personality and cognitive status. J Neurol (2012) 0.83
Major life events and risk of Parkinson's disease. Mov Disord (2010) 0.83
Reduced risk of Parkinson's disease associated with lower body mass index and heavy leisure-time physical activity. Eur J Epidemiol (2014) 0.82
Impulsive and compulsive behaviors in Parkinson's disease. Annu Rev Clin Psychol (2013) 0.82
Altruistic punishment in patients with Parkinson's disease with and without impulsive behaviour. Neuropsychologia (2010) 0.80
Gut feelings about smoking and coffee in Parkinson's disease. Mov Disord (2014) 0.80
Altered dynamics between neural systems sub-serving decisions for unhealthy food. Front Neurosci (2014) 0.80
History of smoking and olfaction in Parkinson's disease. Mov Disord (2014) 0.79
Impulse control disorders in Parkinson's disease: background and update on prevention and management. Neurodegener Dis Manag (2012) 0.79
Alcohol Consumption and Parkinson's Disease Risk: A Review of Recent Findings. J Parkinsons Dis (2015) 0.78
Personality characteristics and motor skills attributed to occupations in Parkinson disease. Cogn Behav Neurol (2011) 0.78
Impulsive-compulsive behaviors in parkin-associated Parkinson disease. Neurology (2016) 0.77
Increased risk of Parkinson disease in patients with carbon monoxide intoxication: a population-based cohort study. Medicine (Baltimore) (2015) 0.77
Dietary fat and antioxidant vitamin intake in patients of neurodegenerative disease in a rural region of Jalisco, Mexico. Nutr Neurosci (2013) 0.77
Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson's patients. Eur J Clin Pharmacol (2016) 0.76
Trait Impulsivity and Anhedonia: Two Gateways for the Development of Impulse Control Disorders in Parkinson's Disease? Front Psychiatry (2016) 0.75
Do gamblers eat more salt? Testing a latent trait model of covariance in consumption. J Behav Addict (2015) 0.75
Personality and addictive behaviours in early Parkinson's disease and REM sleep behaviour disorder. Parkinsonism Relat Disord (2017) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res (1983) 41.26
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry (1992) 33.67
The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev (1993) 19.60
Statistical methods in cancer research. Volume I - The analysis of case-control studies. IARC Sci Publ (1980) 15.47
Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc (1993) 9.90
Effect of viewing smoking in movies on adolescent smoking initiation: a cohort study. Lancet (2003) 9.03
The assessment of alcohol consumption by a simple self-administered questionnaire. Am J Epidemiol (1991) 5.60
A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol (2002) 3.87
Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Mov Disord (2004) 2.84
Parkinson's disease in 65 pairs of twins and in a set of quadruplets. Neurology (1983) 2.47
Smoking, nicotine and Parkinson's disease. Trends Neurosci (2004) 1.74
Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: a PET/[11C]raclopride study in healthy men. Neuropsychopharmacology (2002) 1.72
Dopamine-related personality traits in Parkinson's disease. Neurology (1993) 1.69
The personality associated with Parkinson's disease. Curr Psychiatry Rep (2000) 1.69
Increased risk of Parkinson's disease after depression: a retrospective cohort study. Neurology (2002) 1.52
A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson's disease. Neurology (1998) 1.52
Personality measures as predictors of smoking initiation and cessation in the UNC Alumni Heart Study. Health Psychol (1994) 1.33
Coffee consumption, gender, and Parkinson's disease mortality in the cancer prevention study II cohort: the modifying effects of estrogen. Am J Epidemiol (2004) 1.31
Dopamine D2 receptors in the insular cortex and the personality trait of novelty seeking. Neuroimage (2001) 1.30
The pre-morbid personality of patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (1985) 1.29
Smoking and Parkinson's disease: systematic review of prospective studies. Mov Disord (2004) 1.28
Endogenous dopamine release after pharmacological challenges in Parkinson's disease. Ann Neurol (2003) 1.10
Co-occurrent use of cigarettes, alcohol, and coffee in healthy, community-living men and women. Health Psychol (1985) 1.06
Alcohol consumption and the incidence of Parkinson's disease. Ann Neurol (2003) 1.05
Insular dopamine D2 receptors and novelty seeking personality in Parkinson's disease. Mov Disord (2004) 1.03
Personality correlates of [18F]dopa striatal uptake: results of positron-emission tomography in Parkinson's disease. J Neuropsychiatry Clin Neurosci (1995) 1.01
Depression in Parkinson's disease: a psychosocial viewpoint. Adv Neurol (1995) 0.93
Sensation-seeking and emotional disturbances in depression: relationships and evolution. J Affect Disord (1995) 0.87
The Tridimensional Personality Questionnaire as a predictor of relapse in detoxified alcohol dependents. The European Fluvoxamine in Alcoholism Study Group. Alcohol Clin Exp Res (1999) 0.86
Sensation-seeking, life events and depression. The Cardiff Depression Study. Br J Psychiatry (2001) 0.83
Psychological characteristics and subjective intolerance for xenobiotic agents of normal young adults with trait shyness and defensiveness. A parkinsonian-like personality type? J Nerv Ment Dis (1994) 0.81
Meta-analysis for epidemiologic studies on the relationship between smoking and Parkinson's disease. J Epidemiol (2001) 0.80
Temporary deterioration in parkinsonian signs after modest alcohol intake. Mov Disord (1992) 0.79
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry (1992) 33.67
The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry (1988) 14.72
Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain (1991) 8.16
A film of patients with movement disorders made in Queen Square, London in the Mid-1920s by Samuel Alexander Kinnier Wilson. Mov Disord (2011) 6.45
What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology (1992) 6.03
Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry (2000) 3.89
Striatonigral degeneration. A clinicopathological study. Brain (1990) 3.70
Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's disease. J Neurol Neurosurg Psychiatry (1989) 3.53
Neuropathological features of Alzheimer's disease in non-demented parkinsonian patients. J Neurol Neurosurg Psychiatry (1991) 3.38
Evidence for striatal dopamine release during a video game. Nature (1998) 3.28
Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology (2001) 3.25
The impact of treatment with levodopa on Parkinson's disease. Q J Med (1980) 3.14
Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD. Neurology (2008) 3.10
Does levodopa accelerate the pathologic process in Parkinson disease brain? Neurology (2011) 3.10
A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol (1993) 3.00
Levodopa in the treatment of Parkinson's disease: current controversies. Mov Disord (2004) 2.90
25 years' experience with lymphangiomas in children. J Pediatr Surg (1999) 2.85
Subcutaneous apomorphine in parkinsonian on-off oscillations. Lancet (1988) 2.80
Neuropsychology of fear and loathing. Nat Rev Neurosci (2001) 2.68
Cognitive deficits in the early stages of Parkinson's disease. Brain (1983) 2.65
Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol (1994) 2.65
Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. J Med Genet (2005) 2.56
Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain (1991) 2.52
PINK1 protein in normal human brain and Parkinson's disease. Brain (2006) 2.49
Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Ann Neurol (1990) 2.45
Refining the perfusion-diffusion mismatch hypothesis. Stroke (2005) 2.44
Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J Neurochem (1989) 2.44
Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson's disease. J Neurol Neurosurg Psychiatry (1997) 2.42
The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson's disease. Neurology (1997) 2.36
Apomorphine test to predict dopaminergic responsiveness in parkinsonian syndromes. Lancet (1990) 2.30
Parkinson's Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl (1993) 2.27
Volcanic ash and respiratory symptoms in children on the island of Montserrat, British West Indies. Occup Environ Med (2003) 2.25
Differential effects of nef on HIV replication: implications for viral pathogenesis in the host. Science (1989) 2.25
Spinal internuncial neurones in progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry (1979) 2.20
Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology (2000) 2.19
Clinical usefulness of magnetic resonance imaging in multiple system atrophy. J Neurol Neurosurg Psychiatry (1998) 2.19
A study of performance on tests from the CANTAB battery sensitive to frontal lobe dysfunction in a large sample of normal volunteers: implications for theories of executive functioning and cognitive aging. Cambridge Neuropsychological Test Automated Battery. J Int Neuropsychol Soc (1998) 2.13
Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J Neurochem (1997) 2.10
Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord (2000) 2.10
Low-dose olanzapine for levodopa induced dyskinesias. Neurology (2000) 2.03
Practice parameters for the assessment and treatment of anxiety disorders. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry (1993) 2.03
The neuropathology, pathophysiology and genetics of multiple system atrophy. Neuropathol Appl Neurobiol (2012) 2.03
Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Brain Res Mol Brain Res (1995) 1.98
Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology (2001) 1.95
Asymmetry of substantia nigra neuronal loss in Parkinson's disease and its relevance to the mechanism of levodopa related motor fluctuations. J Neurol Neurosurg Psychiatry (1989) 1.95
Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol (2000) 1.95
The H1c haplotype at the MAPT locus is associated with Alzheimer's disease. Hum Mol Genet (2005) 1.94
A clinico-pathological study of subtypes in Parkinson's disease. Brain (2009) 1.91
Respiratory symptoms in Tasmanian adolescents: a follow up of the 1961 birth cohort. Aust N Z J Med (1984) 1.88
What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. 1992. Neurology (2001) 1.87
Effects of educational and psychosocial interventions for adolescents with diabetes mellitus: a systematic review. Health Technol Assess (2001) 1.87
On-off fluctuations in Parkinson's disease. A clinical and neuropharmacological study. Brain (1984) 1.83
A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J Neurochem (1997) 1.83
The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease. Neuropathol Appl Neurobiol (1989) 1.79
Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease. Arch Neurol (1995) 1.79
Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation. Neurology (2005) 1.77
The amino acid sequence of bovine parathyroid hormone I. Hoppe Seylers Z Physiol Chem (1970) 1.75
Acute movement disorders with bilateral basal ganglia lesions in uremia. Mov Disord (1998) 1.74
A clinical study of Gilles de la Tourette syndrome in the United Kingdom. J Neurol Neurosurg Psychiatry (1984) 1.72
Neurological deterioration in young adults with phenylketonuria. Lancet (1990) 1.71
Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J Neurol Neurosurg Psychiatry (1991) 1.69
A case-control study of the relation between plasma selenium and asthma in European populations: a GAL2EN project. Allergy (2008) 1.66
Deprenyl in Parkinson's disease. Lancet (1977) 1.66
Ten-year follow-up of three different initial treatments in de-novo PD: a randomized trial. Neurology (2001) 1.64
A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia. Thorax (2006) 1.62
Tremor in Parkinson's disease and serotonergic dysfunction: an 11C-WAY 100635 PET study. Neurology (2003) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
New pathologic observations in juvenile onset parkinsonism with dystonia. Neurology (1991) 1.57
Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis (1997) 1.57
A comparison of clinical and pathological features of young- and old-onset Parkinson's disease. Neurology (1988) 1.57
Tau gene and Parkinson's disease: a case-control study and meta-analysis. J Neurol Neurosurg Psychiatry (2004) 1.56
The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology (1986) 1.55
Subcutaneous apomorphine in the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry (1990) 1.54
Cerebral tuberculomas developing during treatment of tuberculous meningitis. Lancet (1980) 1.51
Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis. J Neurol Neurosurg Psychiatry (2003) 1.51
Botulinum toxin treatment in spasmodic torticollis. J Neurol Neurosurg Psychiatry (1990) 1.50
Incidental Lewy body disease in black Africans. Lancet (1994) 1.50
Alpha-tocopherol levels in brain are not altered in Parkinson's disease. Ann Neurol (1992) 1.49
Association of body mass index with respiratory symptoms and atopy: results from the European Community Respiratory Health Survey. Clin Exp Allergy (2002) 1.49
The JAK2 V617F mutation is detectable in granulocyte populations at greater than two copies per cell among individuals with myeloproliferative disorders. Leukemia (2007) 1.47
Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies. Neurology (1999) 1.46
Effects of successful parathyroidectomy on altered arterial reactivity in patients with hypercalcaemia: results of a 3-year follow-up study. Clin Endocrinol (Oxf) (2000) 1.45
The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. Brain (2001) 1.44
Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain (1987) 1.44
Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study. J Neurol Neurosurg Psychiatry (2004) 1.44
Bradyphrenia in Parkinson's disease and psychomotor retardation in depressive illness. An experimental study. Brain (1987) 1.44
Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine. Ann Neurol (1992) 1.43
Patterns of regional cerebral blood flow in corticobasal degeneration studied using HMPAO SPECT; comparison with Parkinson's disease and normal controls. Mov Disord (1995) 1.43
Idiopathic Parkinson's disease combined with multiple system atrophy. A clinicopathological report. Mov Disord (1991) 1.42
Parkinsonism following electrical injury to the hand. Mov Disord (1998) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Increased nigral iron content in postmortem parkinsonian brain. Lancet (1987) 1.39
Transplantation in Parkinson's disease. Br J Hosp Med (1989) 1.39
The psychopathology of the Gilles de la Tourette syndrome. A phenomenological analysis. Br J Psychiatry (1988) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Sign language tics in a prelingually deaf man. Mov Disord (2000) 1.38
Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea. Neurology (2002) 1.38
Synthetic, structural and biological studies of the ubiquitin system: the total chemical synthesis of ubiquitin. Biochem J (1994) 1.38
Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease. Ann Neurol (1994) 1.36